gross profit bridgeinconsistent2018-12-31
Withheld: gross profit could not be reconciled with the rest of this filer’s statement.
Revenue
$2.31B
Fiscal year ended 2025-12-31Operating income
-$309.91M
Fiscal year ended 2025-12-31Free cash flow
$109.11M
Fiscal year ended 2025-12-31Natera, Inc. (NTRA) reported revenue of $2.31B and net income of -$208.16M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Natera, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820.22M | $625.49M | $391.00M | $302.33M | $257.65M | $209.62M | $212.51M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $158.08M | $135.51M | $134.49M |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $78.02M |
| Operating income | -$309.91M | -$222.29M | -$446.24M | -$541.04M | -$468.17M | -$216.28M | -$116.29M | -$114.63M | -$135.34M | -$101.05M |
| Net income | -$208.16M | -$190.43M | -$434.80M | -$547.80M | -$471.72M | -$229.74M | -$124.83M | -$128.15M | -$137.63M | -$100.33M |
| Research & development | $624.11M | $404.14M | $320.68M | $316.42M | $264.21M | $100.04M | $51.36M | $51.36M | $50.06M | $41.86M |
| Weighted-average diluted shares | shares 136.72M | shares 124.72M | shares 115.00M | shares 98.41M | shares 90.56M | shares 81.01M | shares 69.56M | shares 57.85M | shares 53.60M | shares 51.58M |
| Pretax income | -$268.09M | -$189.73M | -$434.53M | -$546.82M | -$471.10M | -$229.64M | -$122.83M | -$127.83M | -$137.17M | -$100.18M |
| Income tax expense | -$59.93M | $695.00K | $271.00K | $978.00K | $618.00K | $98.00K | $2.00M | $321.00K | $454.00K | $142.00K |
| Diluted EPS | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 |
| Selling, general & administrative | $1.18B | $841.31M | $618.31M | $588.59M | $511.03M | $303.63M | $206.18M | $154.87M | $155.31M | $136.13M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | $466.00M | $84.39M | $48.67M | $61.93M | $46.41M | $12.62M | $15.26M |
| Total assets | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932.15M | $582.66M | $268.17M | $214.61M | $210.68M |
| Current assets | $1.50B | $1.38B | $1.26B | $1.21B | $1.09B | $862.66M | $523.17M | $240.52M | $180.62M | $174.12M |
| Total liabilities | $685.93M | $465.32M | $676.37M | $688.73M | $583.18M | $445.92M | $303.94M | $236.01M | $189.20M | $104.20M |
| Current liabilities | $441.23M | $344.04M | $307.27M | $310.50M | $218.96M | $199.05M | $179.87M | $113.98M | $105.56M | $96.42M |
| Total equity incl. NCI | $1.71B | $1.20B | $765.33M | $705.74M | $653.30M | $486.24M | $278.71M | $32.16M | $25.42M | $143.58M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $68.44M | $44.74M | $40.76M | $35.41M | $26.91M | $20.03M | $12.39M | $13.63M | $9.00M | $6.41M |
| Accounts receivable | $296.53M | $314.16M | $278.29M | $244.38M | $122.07M | $78.56M | $53.35M | $62.22M | $44.09M | $13.40M |
| Goodwill | $141.07M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | Unavailable | Unavailable | $282.94M | $281.65M | $280.39M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $33.16M | $34.92M | $15.00M | $31.15M | $27.21M | $8.10M | $8.60M | $14.59M | $8.53M | $11.48M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $215.30M | $135.66M | -$246.96M | -$431.50M | -$335.24M | -$182.51M | -$63.44M | -$70.58M | -$97.82M | -$74.05M |
| Capital expenditures | $106.19M | $66.42M | $39.20M | $47.70M | $41.03M | $19.60M | $4.97M | $3.88M | $9.87M | $23.14M |
| Investing cash flow | -$132.21M | $137.62M | $168.50M | $330.34M | -$205.19M | -$331.46M | -$266.35M | -$5.16M | $13.78M | $47.03M |
| Financing cash flow | $47.46M | $30.20M | $254.46M | $482.64M | $576.19M | $500.85M | $340.77M | $113.72M | $80.37M | $13.18M |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -$2.64M | -$13.69M |
| Stock-based compensation | $354.40M | $274.43M | $191.81M | $152.38M | $115.22M | $50.17M | $28.62M | $14.20M | $11.40M | $10.60M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $41.76M | $30.97M | $24.10M | $16.70M | $11.25M | $8.61M | $7.73M | $7.50M | $7.14M | $6.18M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $109.11M | $69.24M | -$286.15M | -$479.20M | -$376.27M | -$202.12M | -$68.41M | -$74.46M | -$107.69M | -$97.19M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 36.7% |
| Operating margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.8% | -55.3% | -38.5% | -44.5% | -64.6% | -47.6% |
| FCF margin | 4.7% | 4.1% | -26.4% | -58.4% | -60.2% | -51.7% | -22.6% | -28.9% | -51.4% | -45.7% |
| SBC / revenue | 15.4% | 16.2% | 17.7% | 18.6% | 18.4% | 12.8% | 9.5% | 5.5% | 5.4% | 5.0% |
| Current ratio | 3.39x | 4.00x | 4.10x | 3.90x | 4.99x | 4.33x | 2.91x | 2.11x | 1.71x | 1.81x |
| Revenue YoY growth | 35.9% | 56.7% | 32.0% | 31.1% | 60.0% | 29.3% | 17.3% | 22.9% | -1.4% | Unavailable |
| Net margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -65.7% | -47.2% |
| R&D / revenue | 27.1% | 23.8% | 29.6% | 38.6% | 42.2% | 25.6% | 17.0% | 19.9% | 23.9% | 19.7% |
| CapEx / revenue | 4.6% | 3.9% | 3.6% | 5.8% | 6.6% | 5.0% | 1.6% | 1.5% | 4.7% | 10.9% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NTRA in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-09View SEC filing
Reconciliation checks needing review
4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2017-12-31
Withheld: gross profit could not be reconciled with the rest of this filer’s statement.
cash flow reconciliationreview2017-12-31
Operating, investing and financing flows differ from the reported change in cash by 1033000, beyond tolerance 1000000.
balance equationreview2016-12-31
Difference 37101000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.